Researchers sought to highlight several recent advances in the epidemiology, pathogenesis, clinical features, investigation, acute management, and secondary prevention of cerebrovascular diseases in patients with hematological diseases.
To learn more about the potential role of cannabinoids in the management of sleep disorders, we interviewed Aleksandra M. Kwasnik, MD, who recently coauthored a review on the topic.
Mask-related side effects have been cited as the most important factor influencing adherence to continuous positive airway pressure (CPAP) therapy.
Tori Rodriguez, MA, LPC, discusses the progression of care for patients with Duchenne muscular dystrophy during the COVID-19 pandemic.
Among the non-motor symptoms of Parkinson’s disease, chronic pain has become a topic of increasing relevance in research and clinical settings.
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Melatonin and other melatonin receptor agonists have demonstrated efficacy in the treatment of circadian rhythm disorders in both pediatric and adult populations.
Accumulating evidence suggests that COVID-19 can lead to neurological complications.
